Does pRION-1 scales analysis support use of functional outcome measures in prion disease?
Our findings have implications for the choice of primary outcome measure in prion disease clinical trials. Prion disease presents the unusual opportunity to follow patients with a neurodegenerative disease through their entire clinical course, and this provides insights relevant to designing outcome measures in related conditions.
Polar coordinates can be applied to cephalometry to accurately and integrally describe maxillofacial profile features. There are minor differences between the profile features of beautiful men and women, and the differences are mainly shown in mandible and the fullness of lips.